Matches in SemOpenAlex for { <https://semopenalex.org/work/W2000669554> ?p ?o ?g. }
- W2000669554 endingPage "1750" @default.
- W2000669554 startingPage "1750" @default.
- W2000669554 abstract "Biliary atresia is the most common cause of end-stage liver disease in children. Controversy exists as to whether use of steroids after hepatoportoenterostomy improves clinical outcome.To determine whether the addition of high-dose corticosteroids after hepatoportoenterostomy is superior to surgery alone in improving biliary drainage and survival with the native liver.The multicenter, double-blind Steroids in Biliary Atresia Randomized Trial (START) was conducted in 140 infants (mean age, 2.3 months) between September 2005 and February 2011 in the United States; follow-up ended in January 2013.Participants were randomized to receive intravenous methylprednisolone (4 mg/kg/d for 2 weeks) and oral prednisolone (2 mg/kg/d for 2 weeks) followed by a tapering protocol for 9 weeks (n = 70) or placebo (n = 70) initiated within 72 hours of hepatoportoenterostomy.The primary end point (powered to detect a 25% absolute treatment difference) was the percentage of participants with a serum total bilirubin level of less than 1.5 mg/dL with his/her native liver at 6 months posthepatoportoenterostomy. Secondary outcomes included survival with native liver at 24 months of age and serious adverse events.The proportion of participants with improved bile drainage was not statistically significantly improved by steroids at 6 months posthepatoportoenterostomy (58.6% [41/70] of steroids group vs 48.6% [34/70] of placebo group; adjusted relative risk, 1.14 [95% CI, 0.83 to 1.57]; P = .43). The adjusted absolute risk difference was 8.7% (95% CI, -10.4% to 27.7%). Transplant-free survival was 58.7% in the steroids group vs 59.4% in the placebo group (adjusted hazard ratio, 1.0 [95% CI, 0.6 to 1.8]; P = .99) at 24 months of age. The percentage of participants with serious adverse events was 81.4% [57/70] of the steroids group and 80.0% [56/70] of the placebo group (P > .99); however, participants receiving steroids had an earlier time of onset of their first serious adverse event by 30 days posthepatoportoenterostomy (37.2% [95% CI, 26.9% to 50.0%] of steroids group vs 19.0% [95% CI, 11.5% to 30.4%] of placebo group; P = .008).Among infants with biliary atresia who have undergone hepatoportoenterostomy, high-dose steroid therapy following surgery did not result in statistically significant treatment differences in bile drainage at 6 months, although a small clinical benefit could not be excluded. Steroid treatment was associated with earlier onset of serious adverse events in children with biliary atresia.clinicaltrials.gov Identifier: NCT00294684." @default.
- W2000669554 created "2016-06-24" @default.
- W2000669554 creator A5010272022 @default.
- W2000669554 creator A5011638705 @default.
- W2000669554 creator A5014383358 @default.
- W2000669554 creator A5017679725 @default.
- W2000669554 creator A5020707089 @default.
- W2000669554 creator A5022454374 @default.
- W2000669554 creator A5024036340 @default.
- W2000669554 creator A5028366160 @default.
- W2000669554 creator A5037310152 @default.
- W2000669554 creator A5038339390 @default.
- W2000669554 creator A5040962057 @default.
- W2000669554 creator A5046642925 @default.
- W2000669554 creator A5047507638 @default.
- W2000669554 creator A5056406094 @default.
- W2000669554 creator A5058001581 @default.
- W2000669554 creator A5060481702 @default.
- W2000669554 creator A5063054175 @default.
- W2000669554 creator A5072245226 @default.
- W2000669554 creator A5072945397 @default.
- W2000669554 creator A5079795365 @default.
- W2000669554 creator A5082509183 @default.
- W2000669554 creator A5084776825 @default.
- W2000669554 creator A5085821936 @default.
- W2000669554 creator A5089292376 @default.
- W2000669554 date "2014-05-07" @default.
- W2000669554 modified "2023-10-05" @default.
- W2000669554 title "Use of Corticosteroids After Hepatoportoenterostomy for Bile Drainage in Infants With Biliary Atresia" @default.
- W2000669554 cites W111235152 @default.
- W2000669554 cites W1500127981 @default.
- W2000669554 cites W1563569023 @default.
- W2000669554 cites W1938307310 @default.
- W2000669554 cites W1980135050 @default.
- W2000669554 cites W1992155739 @default.
- W2000669554 cites W2005491023 @default.
- W2000669554 cites W2018032275 @default.
- W2000669554 cites W2021751540 @default.
- W2000669554 cites W2022394007 @default.
- W2000669554 cites W2022780831 @default.
- W2000669554 cites W2035792047 @default.
- W2000669554 cites W2036898637 @default.
- W2000669554 cites W2039442002 @default.
- W2000669554 cites W2041753938 @default.
- W2000669554 cites W2053564787 @default.
- W2000669554 cites W2060954288 @default.
- W2000669554 cites W2072378238 @default.
- W2000669554 cites W2087217939 @default.
- W2000669554 cites W2093068198 @default.
- W2000669554 cites W2096449424 @default.
- W2000669554 cites W2097641440 @default.
- W2000669554 cites W2161635185 @default.
- W2000669554 cites W2165719555 @default.
- W2000669554 cites W3148106702 @default.
- W2000669554 doi "https://doi.org/10.1001/jama.2014.2623" @default.
- W2000669554 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4303045" @default.
- W2000669554 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/24794368" @default.
- W2000669554 hasPublicationYear "2014" @default.
- W2000669554 type Work @default.
- W2000669554 sameAs 2000669554 @default.
- W2000669554 citedByCount "146" @default.
- W2000669554 countsByYear W20006695542014 @default.
- W2000669554 countsByYear W20006695542015 @default.
- W2000669554 countsByYear W20006695542016 @default.
- W2000669554 countsByYear W20006695542017 @default.
- W2000669554 countsByYear W20006695542018 @default.
- W2000669554 countsByYear W20006695542019 @default.
- W2000669554 countsByYear W20006695542020 @default.
- W2000669554 countsByYear W20006695542021 @default.
- W2000669554 countsByYear W20006695542022 @default.
- W2000669554 countsByYear W20006695542023 @default.
- W2000669554 crossrefType "journal-article" @default.
- W2000669554 hasAuthorship W2000669554A5010272022 @default.
- W2000669554 hasAuthorship W2000669554A5011638705 @default.
- W2000669554 hasAuthorship W2000669554A5014383358 @default.
- W2000669554 hasAuthorship W2000669554A5017679725 @default.
- W2000669554 hasAuthorship W2000669554A5020707089 @default.
- W2000669554 hasAuthorship W2000669554A5022454374 @default.
- W2000669554 hasAuthorship W2000669554A5024036340 @default.
- W2000669554 hasAuthorship W2000669554A5028366160 @default.
- W2000669554 hasAuthorship W2000669554A5037310152 @default.
- W2000669554 hasAuthorship W2000669554A5038339390 @default.
- W2000669554 hasAuthorship W2000669554A5040962057 @default.
- W2000669554 hasAuthorship W2000669554A5046642925 @default.
- W2000669554 hasAuthorship W2000669554A5047507638 @default.
- W2000669554 hasAuthorship W2000669554A5056406094 @default.
- W2000669554 hasAuthorship W2000669554A5058001581 @default.
- W2000669554 hasAuthorship W2000669554A5060481702 @default.
- W2000669554 hasAuthorship W2000669554A5063054175 @default.
- W2000669554 hasAuthorship W2000669554A5072245226 @default.
- W2000669554 hasAuthorship W2000669554A5072945397 @default.
- W2000669554 hasAuthorship W2000669554A5079795365 @default.
- W2000669554 hasAuthorship W2000669554A5082509183 @default.
- W2000669554 hasAuthorship W2000669554A5084776825 @default.
- W2000669554 hasAuthorship W2000669554A5085821936 @default.
- W2000669554 hasAuthorship W2000669554A5089292376 @default.
- W2000669554 hasBestOaLocation W20006695542 @default.
- W2000669554 hasConcept C126322002 @default.